Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Pfizer Inc.

    Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine[...]

  • Arrowhead Pharmaceuticals Inc.

    EASL 2022 AROAAT2002

  • NV5 Global Inc.

    Agency Lending – Phase I ESA Considerations for Fannie Mae and Freddie Mac

More

Healthcare

  • Ionis Pharmaceuticals Inc.

    Ionis announces presentation of positive Phase 2b data for chronic[...]

  • Madrigal Pharmaceuticals Inc.

    Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and[...]

  • Paya Holdings Inc.

    Orthodontic practice management software company sees impressive[...]

More

Aurora Cannabis Inc.

06/01/2022 | Press release | Distributed by Public on 06/01/2022 04:02

Voluntary Supplemental Material by Foreign Issuer (Form SUPPL)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | Aurora Cannabis Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Public Companies | Alternative Medicine Companies | Börse Frankfurt | Toronto Stock Exchange (TSX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Börse Hamburg | Börse Hannover | Nasdaq Global Select Market | Aequitas NEO Exchange | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | TSX Alpha Exchange | FINRA Alternative Display Facility (ADF) | OmegaATS | Lynx ATS | Nasdaq CXC | Nasdaq CX2 | Canadian Securities Exchange (CSE) - Pure Trading | NYSE Chicago

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact